1:45 PM (PT)
-
This intensive seminar provides biotech leadership teams with a practical, investor-facing playbook for raising institutional private capital. Designed for companies across stages, from early-stage pl ...Breakout Session
-
Business Development and Investment
-
3:00 PM (PT)
-
The financing and partnering environment for biotech has shifted significantly in recent years. Investors and partners have increasingly prioritized tangible, de-risked assets that offer compelling th ...Breakout Session
- Business Development and Investment
-
-
Since 2023, the China biotech industry has made great advancements in therapeutic innovation. Initially, innovation was predominantly in oncology; however, since 2025 we have seen more and more projec ...Breakout Session
- Business Development and Investment
-
)
.jpg/fit-in/120x9999/filters:no_upscale())
)
)
)
)
)
)
)
)
4:15 PM (PT)
-
After two years of a quiet IPO window, the biotech markets are showing renewed signs of life. A growing number of companies are testing public waters again — but with tighter investor scrutiny, leaner ...Breakout Session
- Business Development and Investment
-
)
.jpg/fit-in/120x9999/filters:no_upscale())
)
)
)
.jpeg)
3:00 PM (PT)
-
Women’s health is now a dynamic arena for innovation, data science, and strategic capital deployment. This session brings together leading investors to discuss where smart capital is flowing and how s ...Breakout Session
- Business Development and Investment
-
.jpg/fit-in/120x9999/filters:no_upscale())
)
)
)
4:15 PM (PT)
-
With federal agencies commitments being uncertain and wavering, many researchers as well as emerging drug and device developers are struggling to find funding or to continue projects. At the same time ...Breakout Session
- Business Development and Investment
-
)
)
)
11:00 AM (PT)
-
As the global biotech ecosystem becomes increasingly interconnected, in-licensing has evolved into a core growth engine, with US–Asia deal-making and NewCo formation continuing to accelerate as compan ...Breakout Session
- Business Development and Investment
-
)
)
)
)
1:45 PM (PT)
-
This session will explore ARPA-H’s unique SBIR/STTR funding opportunities and the distinctive commercialization support designed to propel breakthrough companies forward. Attendees will hear firsthand ...Breakout Session
- Business Development and Investment
-
-
The biotech ecosystem is navigating real headwinds — tighter capital, increasingly complex science, and an increasingly unforgiving path from discovery to clinic. But pressure also creates openings. T ...Breakout Session
- Business Development and Investment
-
)
)
)
)
)
3:00 PM (PT)
-
This panel discussion addresses a critical paradox in biotechnology investment - while female-founded biotech’s demonstrate superior returns, they receive less than 3% of venture funding. This session ...Breakout Session
- Business Development and Investment
-
.jpeg)
)
)
)
4:15 PM (PT)
-
Back by popular demand, this session returns with fresh insights for 2026. Health and science executives will learn how to build and deliver an investor-ready story using LaVoieHealthScience’s LHS Fif ...Breakout Session
- Business Development and Investment
-
)
)
9:00 AM (PT)
-
In an increasingly selective capital environment, a handful of biotechs have managed to defy the odds—closing $100 million-plus financing rounds that fueled major growth, platform expansion, and pipel ...Breakout Session
- Business Development and Investment
-
.jpg/fit-in/64x9999/filters:no_upscale())
)
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}